SecBot SecBot
DEFA14A ·Filed Apr 16, 2026

EBS

Emergent BioSolutions Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed7mo ago SEC0001193125-26-158138
Proxy solicitation materials
Actionable Insight • Neutral

No trading catalyst is present in this filing. The proxy statement is a standard disclosure for an upcoming shareholder meeting. Traders should monitor for any subsequent filings related to voting results or changes in corporate strategy, but this document alone does not signal a material event.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$8.62
T+0 close · Apr 16, 2026 · via day close
Latest settled
−7.08%
T+60 · $8.01
Vs SPY
−14.12%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 16 $8.62entry
  2. T+1 · 7mo ago +2.20%α +0.99% · $8.81
  3. T+5 · 7mo ago −6.15%α −7.13% · $8.09
  4. T+20 · 6mo ago −3.36%α −9.18% · $8.33
  5. T+60 · 4mo ago −7.08%α −14.12% · $8.01
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Emergent BioSolutions Inc. (EBS) filed its definitive proxy statement (DEFA14A) for its 2026 Annual Meeting of Stockholders, scheduled for April 29, 2026. The filing outlines proposals for shareholder voting, including director elections and executive compensation, as part of routine corporate governance. No material changes or activist challenges are indicated.

Key Financial Metrics

Vote
director election
Meeting
2026-04-29

Key Facts

  • Filing is a routine proxy statement (DEFA14A) for the 2026 Annual Meeting of Stockholders
  • Meeting date set for April 29, 2026
  • No indication of dissident or activist involvement
  • Proposals include standard items: election of directors, executive compensation, and shareholder proposals

Financial Impact

No immediate financial impact

none

Risk Factors

  • Low risk of unexpected shareholder proposals or voting outcomes given the routine nature of the filing

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001193125-26-158138
Document: 0001193125-26-158138-index-headers.html0001193125-26-158138
Document: 0001193125-26-158138-index.html0001193125-26-158138
Document: 0001193125-26-158138.txt0001193125-26-158138

Track record

23 reports on EBS

Performance horizon

4 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +14.89% at T+20 after the Apr 29, 2026 report. 4 of 5 went positive at some point.

Filters
  1. Nov 16, 2026today Institutional Cluster Neutral 3/10 Entry $5.76 Now $5.81 +0.96% settles Nov 23
  2. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $5.75 Now $5.81 +1.13% settles Nov 23
  3. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $5.79 Now $5.81 +0.35% settles Nov 23
  4. Nov 4, 202612d ago 8-K Neutral 4/10 Entry $5.85 to $5.89 Now $5.81 −0.68% ▲ +0.68% −2.61% vs SPY
  5. Nov 2, 202614d ago 8-K Bearish 6/10 Entry $6.25 to $6.05 Now $5.81 +7.04% ▲ +3.20% +2.61% vs SPY
  6. Oct 30, 202617d ago Institutional Cluster Neutral 2/10 Entry $6.81 to $6.06 Now $5.81 −14.68% ▼ −11.01% −8.31% vs SPY
  7. Oct 16, 20264w ago 8-K Neutral 3/10 Entry $6.38 to $6.23 Now $5.81 −8.93% ▼ −2.35% −2.44% vs SPY
  8. Oct 7, 20265w ago 144 Neutral 2/10 Entry $6.81 to $7.18 Now $5.81 −14.68% ▲ +5.43% +5.71% vs SPY
  9. Jun 29, 202620w ago 8-K Bullish 5/10 Entry $8.46 to $8.18 Now $5.81 −31.32% ▼ −3.31% −4.70% vs SPY
  10. Jun 4, 202623w ago Press Release Neutral 2/10 Entry $8.44 to $8.39 Now $5.81 −31.16% ▼ −0.59% +1.96% vs SPY
Showing 10 of 23

US Market Status

Market Closed · Opens in 6h 38m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 16, 2026